ANALYSIS: Demand For Pfizer’s COVID Pills Lags Around The World

PARIS, France – Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced testing, and potential for drug interactions, a Reuters review of data and interviews with experts has found. Demand also has been hampered by the perception that Omicron infections are not that severe. … More ANALYSIS: Demand For Pfizer’s COVID Pills Lags Around The World

Pfizer And BioNTech Launch Trial Of Omicron – Targeted COVID Vaccine

PARIS, France – Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trail to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which had eluded some of the protection provided by the original two – dose vaccine regimen. Banking on volunteers in the United States, … More Pfizer And BioNTech Launch Trial Of Omicron – Targeted COVID Vaccine

Pfizer Says Pandemic Could Extend Through 2023, Studies Three – Dose Vaccine Course For Children

PARIS, France – Pfizer Inc. said on Friday the COVID – 19 pandemic could extend through next year and announced plans to develop a three – dose vaccine regimen for children ages 2 to 16, a move that could delay its authorisation. The U.S. pharmaceutical company made its comments as European countries geared up for … More Pfizer Says Pandemic Could Extend Through 2023, Studies Three – Dose Vaccine Course For Children

Pfizer, BioNTech Vaccine Neutralises Omicron With Three Shots

PARIS, France – BioNTech and Pfizer said on Wednesday a three – shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that booster shots could be key to protection against infection from the newly identified variant. The German and U.S. companies said two … More Pfizer, BioNTech Vaccine Neutralises Omicron With Three Shots

EU Okays Increase in mRNA COVID – 19 Vaccine Manufacturing Capacity

Paris / France – – Europe’s medicines regulator said on Tuesday it had approved additional manufacturing sites to increase production capacity of mRNA COVID-19 vaccines developed by Pfizer/BioNTech and Moderna for the region. The recommendations do not require a decision by the European Commission and the sites can become operational immediately, the European Medicines Agency … More EU Okays Increase in mRNA COVID – 19 Vaccine Manufacturing Capacity